Literatura académica sobre el tema "CRISPRko Screening"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "CRISPRko Screening".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "CRISPRko Screening"
Evers, Bastiaan, Katarzyna Jastrzebski, Jeroen P. M. Heijmans, Wipawadee Grernrum, Roderick L. Beijersbergen y Rene Bernards. "CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes". Nature Biotechnology 34, n.º 6 (25 de abril de 2016): 631–33. http://dx.doi.org/10.1038/nbt.3536.
Texto completoWatters, Kyle E., Christof Fellmann, Hua B. Bai, Shawn M. Ren y Jennifer A. Doudna. "Systematic discovery of natural CRISPR-Cas12a inhibitors". Science 362, n.º 6411 (6 de septiembre de 2018): 236–39. http://dx.doi.org/10.1126/science.aau5138.
Texto completoSelle, Kurt, Todd R. Klaenhammer y Rodolphe Barrangou. "CRISPR-based screening of genomic island excision events in bacteria". Proceedings of the National Academy of Sciences 112, n.º 26 (15 de junio de 2015): 8076–81. http://dx.doi.org/10.1073/pnas.1508525112.
Texto completoKampmann, Martin, Max A. Horlbeck, Yuwen Chen, Jordan C. Tsai, Michael C. Bassik, Luke A. Gilbert, Jacqueline E. Villalta et al. "Next-generation libraries for robust RNA interference-based genome-wide screens". Proceedings of the National Academy of Sciences 112, n.º 26 (15 de junio de 2015): E3384—E3391. http://dx.doi.org/10.1073/pnas.1508821112.
Texto completoGöttl, Vanessa L., Ina Schmitt, Kristina Braun, Petra Peters-Wendisch, Volker F. Wendisch y Nadja A. Henke. "CRISPRi-Library-Guided Target Identification for Engineering Carotenoid Production by Corynebacterium glutamicum". Microorganisms 9, n.º 4 (24 de marzo de 2021): 670. http://dx.doi.org/10.3390/microorganisms9040670.
Texto completoGÜLER KARA, Hale, Buket KOSOVA, Eda DOĞAN, Vildan BOZOK ÇETİNTAŞ y Şerif ŞENTÜRK. "CRISPR-Cas Functional Genetic Screening: Traditional Review". Turkiye Klinikleri Journal of Medical Sciences 42, n.º 4 (2022): 311–22. http://dx.doi.org/10.5336/medsci.2022-88507.
Texto completoLanning, Bryan R. y Christopher R. Vakoc. "Single-minded CRISPR screening". Nature Biotechnology 35, n.º 4 (abril de 2017): 339–40. http://dx.doi.org/10.1038/nbt.3849.
Texto completoHaswell, Jeffrey R., Kaia Mattioli, Chiara Gerhardinger, Philipp G. Maass, Daniel J. Foster, Paola Peinado, Xiaofeng Wang, Pedro P. Medina, John L. Rinn y Frank J. Slack. "Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency". PLOS ONE 16, n.º 11 (3 de noviembre de 2021): e0252848. http://dx.doi.org/10.1371/journal.pone.0252848.
Texto completoAncos-Pintado, Raquel, Irene Bragado-García, María Luz Morales, Roberto García-Vicente, Andrés Arroyo-Barea, Alba Rodríguez-García, Joaquín Martínez-López, María Linares y María Hernández-Sánchez. "High-Throughput CRISPR Screening in Hematological Neoplasms". Cancers 14, n.º 15 (25 de julio de 2022): 3612. http://dx.doi.org/10.3390/cancers14153612.
Texto completoSerebrenik, Yevgeniy V. y Ophir Shalem. "CRISPR mutagenesis screening of mice". Nature Cell Biology 20, n.º 11 (8 de octubre de 2018): 1235–37. http://dx.doi.org/10.1038/s41556-018-0224-y.
Texto completoTesis sobre el tema "CRISPRko Screening"
Erard, Nicolas Pascal Jean. "Optimization of molecular tools for high-throughput genetic screening". Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/271895.
Texto completoSheel, Ankur. "Identification of Essential Genes in Hepatocellular Carcinomas using CRISPR Screening". eScholarship@UMMS, 2019. https://escholarship.umassmed.edu/gsbs_diss/1039.
Texto completoRubanova, Natalia. "MasterPATH : network analysis of functional genomics screening data". Thesis, Sorbonne Paris Cité, 2018. http://www.theses.fr/2018USPCC109/document.
Texto completoIn this work we developed a new exploratory network analysis method, that works on an integrated network (the network consists of protein-protein, transcriptional, miRNA-mRNA, metabolic interactions) and aims at uncovering potential members of molecular pathways important for a given phenotype using hit list dataset from “omics” experiments. The method extracts subnetwork built from the shortest paths of 4 different types (with only protein-protein interactions, with at least one transcription interaction, with at least one miRNA-mRNA interaction, with at least one metabolic interaction) between hit genes and so called “final implementers” – biological components that are involved in molecular events responsible for final phenotypical realization (if known) or between hit genes (if “final implementers” are not known). The method calculates centrality score for each node and each path in the subnetwork as a number of the shortest paths found in the previous step that pass through the node and the path. Then, the statistical significance of each centrality score is assessed by comparing it with centrality scores in subnetworks built from the shortest paths for randomly sampled hit lists. It is hypothesized that the nodes and the paths with statistically significant centrality score can be considered as putative members of molecular pathways leading to the studied phenotype. In case experimental scores and p-values are available for a large number of nodes in the network, the method can also calculate paths’ experiment-based scores (as an average of the experimental scores of the nodes in the path) and experiment-based p-values (by aggregating p-values of the nodes in the path using Fisher’s combined probability test and permutation approach). The method is illustrated by analyzing the results of miRNA loss-of-function screening and transcriptomic profiling of terminal muscle differentiation and of ‘druggable’ loss-of-function screening of the DNA repair process. The Java source code is available on GitHub page https://github.com/daggoo/masterPATH
Li, Meng. "Genetic dissection of the exit of pluripotency in mouse embryonic stem cells by CRISPR-based screening". Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/277552.
Texto completoKaemena, Daniel Fraser. "CRISPR/Cas9 genome-wide loss of function screening identifies novel regulators of reprogramming to pluripotency". Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/31184.
Texto completoPetrucci, Teresa. "Building a platform for flexible and scalable testing of genetic editors". Doctoral thesis, Università di Siena, 2021. http://hdl.handle.net/11365/1143160.
Texto completoSczakiel, Henrike Lisa [Verfasser]. "Identifizierung Pathogenese-relevanter Kandidatengene im Hodgkin-Lymphom durch CRISPR/Cas9-basiertes knockout-Screening / Henrike Lisa Sczakiel". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2021. http://d-nb.info/1228859523/34.
Texto completoLam, Phuong T. "Crispr/cas9-mediated genome editing of human pluripotent stem cells to advance human retina regeneration research". Miami University / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=miami1575372014701457.
Texto completoCresson, Marie. "Study of chikungunya virus entry and host response to infection". Thesis, Lyon, 2019. http://www.theses.fr/2019LYSE1050.
Texto completoAlphaviruses are a group of enveloped, positive-sense RNA viruses which are distributed almost worldwide and are responsible for a considerable number of human and animal diseases. Among these viruses, the Chikungunya virus (CHIKV) has recently re-emerged and caused several outbreaks on all continents in the past decade. Despite many studies, molecular mechanisms of chikungunya virus replication and virus-host interactions remain poorly understood. The aim of my project was to better understand and characterize the CHIKV entry and the host factors involved during replication steps in mammals. Several different approaches have been used in this work. As a first step, we have demonstrated a decrease of CHIKV infection after iron treatment in form of ferric ammonium citrate and we have studied the potential role in viral entry of NRAMP2 and TFRC, two proteins involved in iron transport and known receptors for other viruses. On the other hand, we have also focused on two proteins, CD46 and TM9SF2, identified through an RNAi screen in collaboration, in order to determine if they are required as entry factors for chikungunya virus. In a last axis, we have set up and carried out a genome-wide loss of function screen with the CRISPR/Cas9 technology in order to identify host factors important for chikungunya virus entry, replication or virus-induced cell death. Although it appears that screen conditions should be optimized, we have identified potential candidates required for CHIKV infection and we are currently testing them
Mohammad, Jiyan Mageed. "Therapeutic Potential of Piperlongumine for Pancreatic Ductal Adenocarcinoma". Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/31347.
Texto completoNIH
Libros sobre el tema "CRISPRko Screening"
Barilan, Y. Michael, Margherita Brusa y Aaron Ciechanover, eds. Can precision medicine be personal; Can personalized medicine be precise? Oxford University Press, 2022. http://dx.doi.org/10.1093/oso/9780198863465.001.0001.
Texto completoCapítulos de libros sobre el tema "CRISPRko Screening"
Henriksson, Johan. "CRISPR Screening in Single Cells". En Methods in Molecular Biology, 395–406. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9240-9_23.
Texto completoNishiga, Masataka, Lei S. Qi y Joseph C. Wu. "CRISPRi/a Screening with Human iPSCs". En Methods in Molecular Biology, 261–81. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1484-6_23.
Texto completoPort, Fillip y Michael Boutros. "Tissue-Specific CRISPR-Cas9 Screening in Drosophila". En Methods in Molecular Biology, 157–76. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2541-5_7.
Texto completoDeLuca, Sophia y Nenad Bursac. "CRISPR Library Screening in Cultured Cardiomyocytes". En Methods in Molecular Biology, 1–13. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2261-2_1.
Texto completoCarstens, Carsten P., Katherine A. Felts y Sarah E. Johns. "Construction of CRISPR Libraries for Functional Screening". En Synthetic Biology, 139–50. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7795-6_7.
Texto completoWebster, Daniel E., Sandrine Roulland y James D. Phelan. "Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines". En Methods in Molecular Biology, 337–50. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9151-8_16.
Texto completoHaney, Steven A. "High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule Screening". En Methods in Molecular Biology, 113–30. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7357-6_8.
Texto completoKlann, Tyler S., Gregory E. Crawford, Timothy E. Reddy y Charles A. Gersbach. "Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing". En Methods in Molecular Biology, 447–80. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7774-1_25.
Texto completoCarlini, Valentina, Kristjan H. Gretarsson y Jamie A. Hackett. "Genome-Scale CRISPR Screening for Regulators of Cell Fate Transitions". En Methods in Molecular Biology, 91–108. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0958-3_7.
Texto completoShang, Wanjing, Fei Wang, Qi Zhu, Liangyu Wang y Haopeng Wang. "CRISPR/Cas9-Based Genetic Screening to Study T-Cell Function". En Methods in Molecular Biology, 59–70. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0266-9_5.
Texto completoActas de conferencias sobre el tema "CRISPRko Screening"
le Sage, Carlos, Prince Panckier y Bendict CS Cross. "Abstract A186: Dual CRISPRi and CRISPRa screening reveals phenotypic switches in response to BRAF inhibition". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-a186.
Texto completoCross, Benedict CS, Steffen Lawo, Tim ME Scales, Caroline Archer, Jessica Hunt, Alessandro Riccombeni, Leigh Brody et al. "Abstract B163: Genetic screening with CRISPR-Cas9: Proof and principles". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-b163.
Texto completoTedesco, Donato, Paul Diehl, Mikhail Makhanov, Sylvain Baron, Dmitry Suchkov y Alex Chenchik. "Abstract C161: CRISPR/Cas9 genome-wide gRNA library screening platform". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-c161.
Texto completoTan, Jenille M. y Scott E. Martin. "Abstract 73: Exploring arrayed synthetic CRISPR for functional genomic screening". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-73.
Texto completoLi, Wanji. "Development and Application of CRISPR-Mediated Genetic Screening in Oncology". En ICBBE '20: 2020 7th International Conference on Biomedical and Bioinformatics Engineering. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3444884.3444909.
Texto completoWei, Yiliang y Christopher Vakoc. "Abstract 5161: Probing leukemia vulnerabilitiesin vivousing domain-focused CRISPR screening". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-5161.
Texto completoWei, Yiliang y Christopher Vakoc. "Abstract 5161: Probing leukemia vulnerabilitiesin vivousing domain-focused CRISPR screening". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-5161.
Texto completoGrassian, Alexandra R., Julian Fowler, Igor Feldman, Thomas Riera, Darren Harvey, Allison E. Drew, Richard Chesworth et al. "Abstract B78: CRISPR pooled screening identifies differential dependencies on epigenetic pathways". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-b78.
Texto completoVakoc, Christopher. "Abstract IA07: Cancer drug target identification using domain-focused CRISPR screening". En Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.sarcomas17-ia07.
Texto completoBehan, F., F. Iorio, E. Stronach, C. Beaver, R. Moita Santos, J. Saez-Rodriguez, K. Yusa y M. Garnett. "SPOT-012 Large-scale CRISPR screening to identify actionable cancer drug targets". En Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.45.
Texto completo